CFO
ACAD icon

CVA Family Office’s Acadia Pharmaceuticals ACAD Stock Holding History

CVA Family Office’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$496 Sell
23
-27
-54% -$582 ﹤0.01% 1238
2025
Q1 		$831 Hold
50
– – ﹤0.01% 1149
2024
Q4 		$918 Buy
+50
New +$918 ﹤0.01% 1109